Related Experiment Video
Updated: Jun 16, 2026

08:17
Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
Published on: September 22, 2017
[Posterior cortical atrophy. Report of five cases]
Carolina Delgado D1, Archibaldo Donoso S
1Hospital Clínico de la Universidad de Chile. Santiago de Chile.
Summary
Posterior cortical atrophy (PCA), often linked to Alzheimer's disease, primarily affects visual processing and spatial awareness. Early symptoms include visuospatial and visual perceptive deficits, with memory spared initially.
Area of Science:
- Neuroscience
- Neurology
- Ophthalmology
Background:
- Posterior cortical atrophy (PCA) is a rare neurodegenerative syndrome.
- It is frequently associated with underlying Alzheimer's disease pathology.
- PCA presents with distinct initial symptoms affecting visual functions.
Observation:
- The study details five patients (2 males, 3 females; ages 50-56) diagnosed with PCA.
- Ophthalmologic examinations were normal across all participants.
- Clinical manifestations included Balint's and Gerstmann's syndromes, visual agnosia, alexia, and cortical blindness in one case.
Findings:
- Patients exhibited progressive visuospatial and visuo perceptive impairments.
- Structural imaging was inconclusive, but functional imaging (PET, SPECT) revealed occipitotemporal or occipitoparietal deficits.
- These findings highlight functional brain alterations in posterior brain regions.
Implications:
- Early identification of PCA is crucial for timely diagnosis and management.
- Functional neuroimaging plays a key role in diagnosing PCA when structural imaging is inconclusive.
- Understanding PCA's unique presentation aids in differentiating it from other dementia syndromes.
Related Concept Videos
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...